Chronic Non-Healing Crusted Lesion at BCG Site: Localized BCG Complication, Not True TB
A chronic non-healing crusted lesion at a BCG vaccination site most likely represents a localized BCG complication (BCG-itis or local ulceration) rather than true tuberculosis infection, and the majority of these lesions heal spontaneously without requiring anti-TB treatment.
Understanding the Differential
The key distinction here is between:
- BCG vaccine complications (caused by the attenuated Mycobacterium bovis in the vaccine)
- True tuberculosis infection (caused by Mycobacterium tuberculosis)
These are fundamentally different entities, though they can appear similar clinically.
Expected Normal BCG Reactions vs. Complications
Normal Course 1:
- Bluish-red pustule forms within 2-3 weeks
- Ulcerates at ~6 weeks, creating a ~5mm lesion
- Scabs form and heal within 3 months
- Results in permanent scar
When to Suspect a Complication:
If the lesion persists beyond 3 months or shows progressive features, consider BCG-related complications rather than normal healing.
Types of BCG-Related Skin Complications
Local reactions 1:
- Ulceration at vaccination site
- Regional suppurative lymphadenitis with draining sinuses
- Caseous lesions or purulent drainage
- Can persist for several weeks to months after vaccination
- May occur within 5 months post-vaccination but can appear later
Subcutaneous tuberculous granuloma 2, 3:
- Rare local adverse reaction
- Can present as nodules or abscesses
- May develop at or near the injection site
- Histologically shows necrotizing granulomatous inflammation
Critical Diagnostic Approach
1. Timing Assessment
- Complications typically occur within 5 months but can appear years later 1
- Chronic persistence beyond normal 3-month healing suggests complication
2. Microbiological Testing
When evaluating the lesion, obtain:
- Acid-fast stain of lesion material
- Mycobacterial culture (can identify M. bovis BCG strain vs. M. tuberculosis) 4
- PCR/DNA probe to differentiate BCG strain from wild-type TB 5, 4
Important caveat: Many BCG-related skin lesions are culture-negative despite being BCG-related 5, 6. This represents a hypersensitivity/tuberculid reaction rather than active infection.
3. Histopathology
- Necrotizing granulomatous inflammation
- Pyogenic granulomatous changes
- Vascularization and inflammatory cell infiltration
- May be acid-fast bacilli negative
4. Assess for Immunocompromise
Critical: Immunocompromised patients are at higher risk for severe BCG complications 1:
- HIV infection
- Severe combined immunodeficiency
- Other immunosuppressive conditions
- These patients may develop disseminated BCG disease
Management Algorithm
For Localized Non-Adherent Lesions 1:
- Observation alone is appropriate
- Most heal spontaneously without treatment
- Keep clean and bandaged
- Expected resolution: weeks to 2 months 5, 6
For Adherent/Fistulated Lesions 1:
- Consider surgical drainage
- WHO suggests direct instillation of anti-TB drug into the lesion
- This is for mechanical management, not systemic TB treatment
When to Use Anti-TB Treatment 2, 6:
Treatment with anti-tuberculosis drugs should be considered for:
- Subcutaneous granulomas with abscesses or ulcerations 2
- Progressive lesions despite conservative management
- Immunocompromised patients 6
Treatment regimen when indicated 2:
- Isoniazid-based therapy (often monotherapy sufficient)
- Never use pyrazinamide - all BCG strains are resistant 1
Prognosis 6:
- Excellent overall prognosis
- Only 20% of generalized skin reactions required treatment
- 75% of localized lesions required treatment (including surgical procedures)
- All cases cured or subsided
Key Clinical Pitfalls to Avoid
Don't assume it's true TB: The attenuated vaccine strain causes local reactions, not systemic tuberculosis in immunocompetent hosts
Don't rush to treat: Most lesions (80% of generalized, 25% of localized) resolve without anti-TB drugs 6
Don't use pyrazinamide: BCG is inherently resistant 1
Don't forget to assess immune status: Immunocompromised patients require different management and are at risk for disseminated disease 1
Don't confuse with tuberculid reactions: Papulonecrotic tuberculid 5 represents hypersensitivity, not infection - these are culture-negative and self-limited
Reporting Requirement
All suspected adverse reactions to BCG vaccination should be reported to the Vaccine Adverse Event Reporting System (VAERS), as these reactions can occur >1 year after vaccination 1.